Article Details

Credit Suisse Group Cuts PTC Therapeutics (NASDAQ:PTCT) Price Target to $50.00

Retrieved on: 2021-07-30 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

Credit Suisse Group Cuts PTC Therapeutics (NASDAQ:PTCT) Price Target to $50.00. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 150,778 shares of the biopharmaceutical company's stock worth $7,139,000 after buying an additional 135,331 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up